Eplerenone, a 12 selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial 13 infarction, N Engl J Med, vol.348, issue.14, pp.1309-1330, 2003. ,
Extracellular 15 cardiac matrix biomarkers in patients with acute myocardial infarction complicated by left 16 ventricular dysfunction and heart failure: insights from the Eplerenone Post, p.17 ,
, Myocardial Infarction Heart Failure Efficacy and Survival Study (EPHESUS) study. Circulation, vol.1, issue.18, pp.2471-2480, 2009.
,
, Circulating Biomarkers of Myocardial Fibrosis: The Need for a Reappraisal, J Am Coll Cardiol, vol.4, issue.22, pp.2449-56, 2015.
,
, Increased collagen type I synthesis in patients with heart failure of hypertensive origin: 7 relation to myocardial fibrosis, Circulation, vol.110, issue.10, pp.1263-1271, 2004.
Stability of several biochemical markers of bone metabolism, Clin 9 Chem, vol.46, issue.8, pp.1200-1202, 2000. ,